goto contents

Alexander Hawlitschka

Die intrazerebrale Applikation von Botulinum Neurotoxin-A als experimentelle antiparkinsonoide Therapie in verschiedenen Murinae

Universität Rostock, 2020

Abstract: The potential therapeutic use of intracerebral botulinum neurotoxin-A (BoNT-A) injections in a mouse and rat model was comparatively investigated. BoNT-A locally suppresses the release of acetylcholine without systemic side effects. In a rat model of Parkinson's disease, dopamine deficiency in the caudate-putamen complex (striatum) results in striatal hypercholinism. Motor deficits are alleviated by injection of BoNT-A into the striatum. Species differences in the effects of intrastriatally applied BoNT-A on rat and mouse were detected.

postdoctoral thesis   free access    


OPACGVKDataCite Commons


all rights reserved

This work may only be used under the terms of the German Copyright Law (Urheberrechtsgesetz).